Efficacy of Tranexamic acid in the Prevention of Postpartum Haemorrhage following vaginal delivery at a Primary Health Centre in Southern Nigeria

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202411885208906

Enrollment

102

Registered

2024-11-11

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum haemorrhage

Interventions

Intravenous Tranexamic acid

Sterile injection water

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Term pregnancy Cephalic presentation

Exclusion criteria

Exclusion criteria: Allergy to tranexamic acid Coagulopathy Severe Preeclampsia with HELLP syndrome Sickle cell disease Previous history of thromboembolism History of deep vein thrombosis

Design outcomes

Primary

Measure	Time frame
Blood loss and postpartum haemorrhage rate following vaginal delivery	—

Secondary

Measure	Time frame
Side effects of tranexamic acid	—

Countries

Nigeria

Contacts

Public ContactLewis Lebara

Resident Doctor

lewislebara@gmail.com+2348064367248

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026